Primary progressive multiple sclerosis – Life with Disease

Go back

Primary progressive multiple sclerosis (PPMS) is a unique form of MS where symptoms gradually worsen over time without the typical periods of relapse and recovery seen in other types of multiple sclerosis.

Prognosis

Understanding the future course of primary progressive multiple sclerosis requires both sensitivity and honesty. This form of MS follows a different path than more common types of the disease. While PPMS is not considered fatal, it is characterized by a steady progression of symptoms that gradually worsen over time. People with PPMS live nearly as long as the general population, which offers some reassurance even as the condition presents ongoing challenges.

The progression of PPMS varies considerably from person to person. Some individuals experience a slow and gradual worsening of symptoms over many years, while others may face a more rapid decline. There can be periods when symptoms stabilize or remain unchanged, and occasionally there may be times of minor improvement. However, the overall pattern is one of increasing disability over time rather than the relapsing-remitting pattern seen in other forms of MS.[1][6]

Most people receive a PPMS diagnosis when they are in their 40s or 50s, which is notably later than the typical age for relapsing-remitting MS diagnosis. About 10 to 15 percent of all people diagnosed with MS have the primary progressive form. Unlike relapsing-remitting MS, which affects more women than men, PPMS affects men and women in roughly equal numbers.[1][6]

⚠️ Important
While PPMS presents significant challenges, it is important to understand that the condition is not fatal and people with MS can live nearly as long as those without the disease. Treatment options, though limited compared to other MS types, do exist and focus on slowing progression and managing symptoms. Every person’s experience with PPMS is different, and some may experience slower progression than others.

Natural Progression

When left untreated, primary progressive multiple sclerosis follows a characteristic pattern of steady deterioration. From the very beginning of the condition, nervous system problems gradually worsen without the distinct attacks or flare-ups that characterize other forms of MS. This progression occurs because PPMS causes both inflammation and neurodegeneration, which is the progressive loss of function in nerve cells throughout the brain and nervous system.[1]

The underlying mechanism involves the immune system mistakenly attacking healthy parts of the central nervous system, specifically targeting the protective covering around nerve fibers called myelin. This protective sheath is often compared to insulation on an electrical wire. When this covering is damaged, it exposes the actual nerve fiber, which can slow or block the signals being transmitted. Over time, the nerve fibers themselves may also be damaged, not just their protective coating.[2]

As the disease progresses naturally without intervention, people lose brain cells and spinal cord cells at a faster rate than would occur with normal aging. This happens very slowly, usually over decades, and typically shows up as gradual walking difficulty developing over several years. The accumulation of damage to nerve tissue leads to increasing physical disability that steadily worsens rather than coming and going in waves.[2]

The symptoms of PPMS are not entirely obvious at first but increase in severity over time. Early on, someone might notice subtle changes like mild weakness in a leg or slight difficulty with coordination. These symptoms may be easy to dismiss or attribute to other causes. However, as months and years pass, these difficulties become more pronounced and additional symptoms emerge, creating a cumulative effect on physical and cognitive function.[1]

Possible Complications

Primary progressive multiple sclerosis can lead to a range of complications that extend beyond the initial symptoms. As the disease progresses and nerve damage accumulates, various body systems can become affected, creating additional challenges for daily functioning.

One of the most common complications is spasticity, which refers to muscle tightness and stiffness. This can make movement difficult and uncomfortable, affecting a person’s ability to walk, use their hands, or perform other physical activities. The muscle stiffness often worsens over time and can be accompanied by painful muscle spasms that occur unpredictably.[1]

Vision complications can develop as PPMS affects the nerves in the eyes. Some people experience progressive vision loss that cannot be fully corrected with glasses or contact lenses. This can range from blurred vision to more significant impairment that affects reading, driving, and recognizing faces. The gradual nature of these changes can make them particularly challenging to adapt to.[1]

Bladder and bowel dysfunction represents another significant complication. People with PPMS may experience difficulty controlling their bladder, leading to urgency, frequency, or incontinence. Similarly, bowel function can be affected, causing either constipation or loss of control. These complications can be particularly distressing as they impact dignity and require careful management strategies.[1][7]

Sexual dysfunction occurs in many people with PPMS, affecting both physical function and emotional intimacy. This can include decreased sensation, difficulty with arousal, or changes in sexual response. These complications often go undiscussed but can significantly impact quality of life and relationships.[1]

Cognitive complications include difficulties with memory, concentration, and information processing. Some people describe experiencing “brain fog” where thinking feels slower or less clear than before. These cognitive changes can affect work performance, social interactions, and the ability to manage complex tasks. While not everyone with PPMS experiences significant cognitive problems, when they do occur, they can be as limiting as physical symptoms.[1][7]

Mood changes, particularly depression, represent another complication that can emerge during the course of PPMS. The gradual loss of function, combined with the chemical changes occurring in the brain due to the disease process itself, can contribute to feelings of sadness, hopelessness, or anxiety. These emotional complications deserve attention and treatment just as much as physical symptoms.[1]

Impact on Daily Life

Living with primary progressive multiple sclerosis affects virtually every aspect of daily existence, from the most basic physical tasks to complex social and professional interactions. The gradual worsening of symptoms means that people must continually adapt to changing abilities and find new ways to accomplish familiar activities.

Physical activities become increasingly challenging as PPMS progresses. Walking, which many take for granted, often becomes one of the first activities significantly affected. What begins as occasional tripping or a feeling of weakness in one leg can progress to requiring assistive devices like canes, walkers, or eventually wheelchairs. This change in mobility doesn’t just affect the ability to move from place to place, it impacts spontaneity, independence, and the ability to participate in previously enjoyed activities like hiking, dancing, or playing with children or grandchildren.[1][7]

Fatigue in PPMS is not simply feeling tired after exertion. It is a profound, overwhelming exhaustion that can occur without warning and doesn’t necessarily improve with rest. This type of fatigue can make it difficult to work a full day, maintain social commitments, or even complete basic self-care tasks like showering or preparing meals. Many people find they need to carefully budget their energy, prioritizing essential activities and accepting that they may not be able to do everything they once could.[1]

Work life often requires significant adjustments. Some people with PPMS can continue working with accommodations like flexible schedules, ergonomic equipment, or modified duties. Others find that the combination of physical limitations, cognitive challenges, and overwhelming fatigue makes continuing employment difficult or impossible. The decision to reduce hours, change careers, or stop working entirely carries not just financial implications but also affects identity, social connections, and sense of purpose.[13]

Social relationships undergo transformation as well. Friends and family members may struggle to understand the invisible aspects of PPMS, particularly fatigue and cognitive symptoms. Social events that involve standing for long periods, navigating stairs, or dealing with crowds can become difficult or impossible. Some people find their social circles shrinking as they withdraw from activities that have become too challenging, leading to feelings of isolation.[13]

Hobbies and leisure activities may need to be modified or replaced. Someone who loved gardening might need to transition to container gardening at table height. An avid reader might need to use audiobooks if vision problems develop. Finding ways to adapt beloved activities helps maintain quality of life and sense of self, even as the disease progresses.

Coping strategies become essential tools for maintaining quality of life. Many people find that occupational therapy helps them learn new techniques for daily tasks and identify helpful assistive devices. Physical therapy can help maintain strength and flexibility for as long as possible. Joining support groups, either in person or online, provides connection with others who truly understand the challenges of living with PPMS. Some people find that counseling helps them process the grief that comes with progressive loss of function while also building resilience.[13]

⚠️ Important
Adapting to life with PPMS is an ongoing process that requires patience, creativity, and often a willingness to ask for help. While the disease does impose limitations, many people find that with appropriate support and adaptive strategies, they can maintain meaningful activities and relationships. Focus on what you can do rather than what you cannot, and remember that using assistive devices or asking for help is not a sign of weakness but a practical strategy for maintaining independence and quality of life.

Support for Family

Family members and loved ones play a crucial role when someone is living with primary progressive multiple sclerosis, particularly when that person is considering or participating in clinical trials. Understanding how to provide support requires knowledge about both the disease and the research process.

Clinical trials for PPMS are limited compared to trials for other forms of MS. This is partly because PPMS is less common, affecting only about 10 percent of people with MS, and partly because the disease has been more challenging to treat. Currently, only one medication has received approval specifically for treating PPMS, though researchers continue working to develop additional therapies. This makes participation in clinical trials particularly important for the PPMS community, as it represents one of the best hopes for advancing treatment options.[1][7]

Families can assist their loved one in finding appropriate clinical trials by helping search for studies, which are typically listed on clinical trial databases and through MS organizations. This might involve helping navigate websites, making phone calls to research centers, or attending informational sessions together. Many people find that having a family member present during these discussions helps ensure all questions are asked and information is retained.

Preparing for trial participation involves practical considerations where family support proves invaluable. Clinical trials typically require multiple visits to the research site, which may be far from home. Family members can help with transportation, particularly as PPMS often affects mobility and driving ability. They can also help track appointments, manage paperwork, and ensure that study medications or procedures are completed as scheduled.

Understanding what participation entails helps families provide informed support. Clinical trials may involve additional testing beyond standard care, including more frequent MRI scans, blood draws, or neurological examinations. There may be placebo-controlled studies where the person might not receive the active treatment. Families should understand these aspects so they can help their loved one make an informed decision about participation and provide appropriate emotional support throughout the process.

Relatives can serve as additional observers of symptoms and changes. In PPMS, where progression can be gradual and subtle, family members who see the person regularly may notice changes that the individual themselves might not recognize. Keeping notes about symptom changes, new difficulties, or improvements can provide valuable information both for the clinical trial researchers and for the person’s regular medical care team.

Emotional support throughout trial participation cannot be overstated. The hope that comes with trying a new treatment can be accompanied by anxiety about whether it will work, disappointment if it doesn’t show clear benefits, and the stress of additional medical appointments and procedures. Family members can provide encouragement, help maintain perspective, and offer comfort during difficult moments.

Families should also educate themselves about PPMS beyond just the clinical trial aspects. Understanding the nature of the disease, its typical progression, and available supportive care options enables them to be better advocates and more effective sources of support. Many MS organizations offer educational materials and programs specifically designed for family members and caregivers.

Practical support extends to helping with activities that become difficult as the disease progresses. This might include assistance with household tasks, help with medical appointment logistics, or support with adaptive equipment. However, it’s important for families to balance helping with allowing independence. The goal is to provide assistance where truly needed while respecting the person’s autonomy and ability to make their own decisions.

Finally, families must also care for themselves. Supporting someone with a progressive disease is emotionally and physically demanding. Family members benefit from their own support networks, whether through support groups for caregivers, counseling, or simply ensuring they maintain activities and relationships outside of their caregiving role. Taking care of oneself is not selfish, it’s essential for being able to provide sustainable, effective support over the long term.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Ocrelizumab (Ocrevus) – The only FDA-approved disease-modifying drug specifically for treating primary progressive MS; it works by destroying certain cells in the immune system to slow disease progression
  • Ocrelizumab (Ocrevus Zunovo) – A subcutaneous version of ocrelizumab approved in September 2024, offering a twice-yearly under-the-skin dosing option as an alternative delivery method for treating PPMS

Ongoing Clinical Trials on Primary progressive multiple sclerosis

  • Study on the Safety and Effects of YTB323 and Drug Combination in Patients with Progressive Multiple Sclerosis

    Recruiting

    1 1 1
    France Germany Italy Spain
  • Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

    Not yet recruiting

    1 1
    Austria Belgium Bulgaria Croatia Czechia Denmark +14
  • Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis

    Not recruiting

    1 1
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +13
  • Study Comparing Rituximab and Ocrelizumab for Patients with Active Multiple Sclerosis

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Denmark
  • Study on the Safety and Effectiveness of Melatonin and Ocrelizumab for Patients with Primary Progressive Multiple Sclerosis

    Not recruiting

    1 1
    Spain
  • Study on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

    Not recruiting

    1 1 1
    Belgium Bulgaria Croatia France Italy Poland +3
  • Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

    Not recruiting

    1 1 1
    Belgium Bulgaria Denmark France Germany Greece +5
  • Study on Metformin for Delaying Progression in Non-Active Progressive Multiple Sclerosis Patients

    Not recruiting

    1 1
    Belgium

References

https://my.clevelandclinic.org/health/diseases/14202-primary-progressive-multiple-sclerosis-ppms

https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/syc-20350269

https://www.uhhospitals.org/health-information/health-and-wellness-library/article/diseases-and-conditions/primary-progressive-multiple-sclerosis

https://www.ummhealth.org/health-library/primary-progressive-multiple-sclerosis

https://www.cedars-sinai.org/health-library/diseases-and-conditions/p/–primary-progressive-multiple-sclerosis-ppms.html

https://mstrust.org.uk/a-z/primary-progressive-ms

https://www.brighamandwomens.org/neurology/multiple-sclerosis-information/ppms

https://my.clevelandclinic.org/health/diseases/14202-primary-progressive-multiple-sclerosis-ppms

https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/diagnosis-treatment/drc-20350274

https://pmc.ncbi.nlm.nih.gov/articles/PMC10092602/

https://www.brighamandwomens.org/neurology/multiple-sclerosis-information/ppms

https://www.ocrevus.com/patient/ocrevus-101/primary-progressive-multiple-sclerosis.html

https://www.everydayhealth.com/multiple-sclerosis/tips-for-coping-with-a-diagnosis-of-primary-progressive-multiple-sclerosis-ppms/

https://my.clevelandclinic.org/health/diseases/17248-multiple-sclerosis

https://mstrust.org.uk/a-z/primary-progressive-ms

https://www.healthline.com/health/multiple-sclerosis/primary-progressive-ms/activities

https://www.ummhealth.org/health-library/primary-progressive-multiple-sclerosis

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

How is PPMS different from other types of multiple sclerosis?

PPMS differs from other MS types in that symptoms gradually worsen from the beginning without distinct periods of relapse and remission. About 85% of people with MS start with relapsing-remitting MS (RRMS), where symptoms flare up and then improve. With PPMS, there are no clear relapses or recovery periods, just steady progression, though the rate of worsening varies between individuals and there can be times when symptoms stabilize.

What causes primary progressive multiple sclerosis?

The exact cause of PPMS is unknown. Research suggests it involves a combination of genetic predisposition and environmental factors. In PPMS, the immune system mistakenly attacks the protective covering (myelin) around nerve fibers in the brain and spinal cord. While genetics may play a small role, the risk of passing the condition to children is low. Environmental factors like exposure to certain bacteria or viruses may also contribute to developing the condition.

What are the first symptoms of PPMS?

Early symptoms of PPMS are often subtle and may include weakness in one leg, difficulty with walking or coordination, numbness or tingling, vision changes, or unusual fatigue. These symptoms are not entirely obvious at first but gradually increase in severity over time. Many people initially notice they are tripping over one foot or experiencing muscle stiffness, particularly in the legs.

Is there a cure for primary progressive MS?

There is currently no cure for PPMS. However, treatment options exist to help slow disease progression and manage symptoms. Only one medication, ocrelizumab (Ocrevus), has been approved by the FDA specifically for slowing the progression of PPMS. Other treatments focus on managing specific symptoms like depression, fatigue, bladder problems, and muscle stiffness to help maintain quality of life.

How long can you live with primary progressive MS?

PPMS is not considered a fatal disease, and people with MS live nearly as long as the general population. While PPMS does cause progressive disability that worsens over time, it does not significantly shorten lifespan. The focus of care is on managing symptoms, maintaining quality of life, and slowing progression rather than on survival duration.

🎯 Key takeaways

  • PPMS represents only 10-15% of all MS cases, making it significantly less common than relapsing-remitting MS
  • Unlike other MS types, PPMS affects men and women equally rather than predominantly affecting women
  • Symptoms worsen gradually from the beginning without the typical attacks and recoveries seen in other MS forms
  • Only one medication, ocrelizumab (Ocrevus), is specifically approved for treating PPMS
  • People with PPMS are typically diagnosed in their 40s or 50s, about 10-15 years later than those with relapsing-remitting MS
  • While PPMS causes progressive disability, it is not considered fatal and does not significantly shorten lifespan
  • Diagnosis requires at least a year of consistent symptom progression combined with MRI or spinal tap results consistent with MS
  • Maintaining physical activity and exercise can help slow the onset of disabilities and improve overall quality of life